2-(tert-butyl)-6-(3-(tert-butyl)-2-hydroxy-5-methylbenzyl)-4-methylphenylacrylate; 2-(tert-butyl)-6-(3-(tert-butyl)-2-hydroxy-5-methylbenzyl)-4-methylphenyl acrylate; 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) monoacrylate; 2,2'-Methylenebis(6-tert-butyl-4-methylphenol) monoacrylate; 2-(2-Hydroxy-3-tert-butyl-5-methylbenzyl)-4-methyl-6-tert-butylphenyl acrylate; 2-tert-Butyl-6-(3-tert-butyl-2-hydroxy-5-methylbenzyl)-4-methylphenyl acrylate; 2-tert-Butyl-6-(3-tert-butyl-5-methyl-2-hydroxybenzyl)-4-methylphenyl acrylate; 2-tert-Butyl-6-[1-(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenylacrylate; Antioxidant 3052; Bis(2-hydroxy-3-tert-butyl-5-methyl)phenylmethane monoacrylate ; Irganox 3052FF; Sumilizer GM
Irganox 3052 is a fully characterized chemical compound used as a reference standard of API Irganox. The standard offered is compliant with regulatory guidelines. Irganox 3052 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 61167-58-6